As one of the world’s leading experts in pancreatic cancer, Prof Andrew Biankin is all too familiar with the aura of dread ...

Mayo Clinic researchers say they have developed an AI tool that can spot pancreatic cancer years before it is typically ...

The AI model analyzes subtle tissue changes on routine CT scans invisible to human specialists, detecting pancreatic cancer ...

The cancers showing increasing rates include bowel, thyroid, multiple myeloma, liver, kidney and pancreatic cancer, among ...

A model developed at the Mayo Clinic identified early signs of pancreatic cancer in routine scans more than a year before ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of ...

Researchers warn of key new driver of 11 cancers in under-50s – and it’s not smoking or poor diet - A new study has found ...

Former U.S. Senator Ben Sasse of Nebraska was diagnosed with terminal pancreatic cancer. He says a "miracle drug" caused ...

With Pancreatic Cancer Research at an Extraordinary Turning Point, PanCAN Unveils Ambitious 5-Year, $250 Million Campaign to ...

New pancreatic cancer drug nearly doubles survival time in patients - Pancreatic cancer is the only cancer with a five-year survival rate that’s below 20% ...

Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced its long-term data titled ...